CT-868 Improves Glycaemic Control in Type 2 Diabetes
The study evaluated CT-868, a dual GLP-1/GIP receptor agonist, and found it significantly improved glycaemic control in adults with type 2 diabetes.
Research feed
Recently added diabetes research, organized by intervention and outcome.
Sorted by when Dediabetes added each study.
The study evaluated CT-868, a dual GLP-1/GIP receptor agonist, and found it significantly improved glycaemic control in adults with type 2 diabetes.
This study investigated the effects of inspiratory muscle loading on blood flow and glucose levels in patients with type 2 diabetes. It found that loading at 60% of PImax significantly reduced calf blood flow and increased vascular resistance.
This study investigated the effects of a 10-week whole-food plant-based community program on weight and type 2 diabetes outcomes over 36 months. It found significant weight loss but non-significant trends in other health markers.
This study examined the effects of sucrose intake on metabolic parameters in individuals with Type 1 Diabetes, finding significant differences in C-reactive protein levels between diet groups.
This study evaluated the effectiveness of group-based dietary interventions on glycemic control in adults with Type 1 diabetes, finding unclear effectiveness across different measures.
This study compared the safety and effectiveness of low-carbohydrate, Mediterranean, and low-fat diets on renal function in moderately obese individuals with or without type 2 diabetes.
This study examined the effects of dietary protein and fiber on bone turnover in adults with abdominal obesity and type 2 diabetes, finding no significant changes in key bone turnover markers.
This study evaluated the effects of Lactobacillus rhamnosus HN001 and oat-derived beta-glucan on adults with pre-diabetes, finding no significant differences in key metabolic outcomes.
Combined diet and exercise intervention in adults with prediabetes.
The iLet Bionic Pancreas System was evaluated for its effectiveness in improving glycemia in adults with Type 1 Diabetes, showing significant improvements in average glucose levels and time in range.
Latest Evidence
Build your workspace to keep track of the latest diabetes research.